Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tobias Ruck

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Current Opinion in Neurology|June 5, 2025
Inclusion body myositis - what are new lines of pathogenesis and therapy?Karsten Krause, Tobias Ruck, Felix Kleefeld
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 8, 2018
Cytokine signaling in multiple sclerosis: Lost in translationKerstin Göbel, Tobias Ruck, Sven G Meuth
Neural Regeneration Research|July 23, 2015
Blood-brain barrier modeling: challenges and perspectivesTobias Ruck, Stefan Bittner, Sven G Meuth
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|May 16, 2023
[Meningitis in the Emergency Room]Liesa Regner-Nelke, Tobias Ruck, Sven G Meuth
Frontiers in Neurology|March 19, 2020
Editorial: Pathophysiologic Insights From Biomarker Studies in Neurological DisordersStefan Bittner, Marcello Moccia, Tobias Warnecke, et al.
Therapeutic Advances in Neurological Disorders|March 12, 2019
Understanding the burden of refractory myasthenia gravisChristiane Schneider-Gold, Tim Hagenacker, Nico Melzer, et al.
Human Immunology|January 31, 2016
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevanceSusann Pankratz, Tobias Ruck, Sven G Meuth, et al.
Brain : a Journal of Neurology|December 20, 2021
Next-generation antibody-based therapies in neurologyTobias Ruck, Falk Nimmerjahn, Heinz Wiendl, et al.
International Journal of Molecular Sciences|July 25, 2015
Alemtuzumab in Multiple Sclerosis: Mechanism of Action and BeyondTobias Ruck, Stefan Bittner, Heinz Wiendl, et al.
Autoimmunity Reviews|March 14, 2017
Animal models in idiopathic inflammatory myopathies: How to overcome a translational roadblock?Ali Maisam Afzali, Tobias Ruck, Heinz Wiendl, et al.
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Current Opinion in Neurology|June 5, 2025
Inclusion body myositis - what are new lines of pathogenesis and therapy?Karsten Krause, Tobias Ruck, Felix Kleefeld
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 8, 2018
Cytokine signaling in multiple sclerosis: Lost in translationKerstin Göbel, Tobias Ruck, Sven G Meuth
Neural Regeneration Research|July 23, 2015
Blood-brain barrier modeling: challenges and perspectivesTobias Ruck, Stefan Bittner, Sven G Meuth
Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|May 16, 2023
[Meningitis in the Emergency Room]Liesa Regner-Nelke, Tobias Ruck, Sven G Meuth
Frontiers in Neurology|March 19, 2020
Editorial: Pathophysiologic Insights From Biomarker Studies in Neurological DisordersStefan Bittner, Marcello Moccia, Tobias Warnecke, et al.
Therapeutic Advances in Neurological Disorders|March 12, 2019
Understanding the burden of refractory myasthenia gravisChristiane Schneider-Gold, Tim Hagenacker, Nico Melzer, et al.
Human Immunology|January 31, 2016
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevanceSusann Pankratz, Tobias Ruck, Sven G Meuth, et al.
Brain : a Journal of Neurology|December 20, 2021
Next-generation antibody-based therapies in neurologyTobias Ruck, Falk Nimmerjahn, Heinz Wiendl, et al.
International Journal of Molecular Sciences|July 25, 2015
Alemtuzumab in Multiple Sclerosis: Mechanism of Action and BeyondTobias Ruck, Stefan Bittner, Heinz Wiendl, et al.
Autoimmunity Reviews|March 14, 2017
Animal models in idiopathic inflammatory myopathies: How to overcome a translational roadblock?Ali Maisam Afzali, Tobias Ruck, Heinz Wiendl, et al.
Pageof 25